Project Grant R35GM156571

Award Date 1/14/25
Completion Date 11/30/29
Dollars Obligated $440K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $541,967 to the University of Chicago to investigate the mechanical behaviors of cells and their impact on physiological processes and diseases. The research aims to expand the understanding of adherent cell mechanics and mechanobiology, focusing on the force-sensitive remodeling of cell-cell adhesions and the role of LIM...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to elucidate the underlying molecular mechanisms of cellular mechanosensitivity. The $387,662 award to Duke University will enable the development of novel biosensors and techniques to investigate how mechanical forces and protein phosphorylation regulate the mechanical state and force transmission capabilities of key linker...
This Project Grant award for $479,487 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The funding supports research at The Johns Hopkins University to investigate how key physical cues, such as extracellular fluid viscosity, microenvironmental stiffness, and cellular confinement, regulate cell migration and function. The research aims to develop a comprehensive understanding of how these...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $372,100 to the University of Wisconsin - Madison to develop novel "mechanoimaging" technologies that can measure and program piconewton-scale mechanical forces exerted by individual cell receptors in viscoelastic biomaterials. The goal is to quantify how cells, including fibroblasts, cancer cells, and T cells, physically...
The National Institute of General Medical Sciences (NIGMS) awarded a $389,211 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Massachusetts (UMass) Amherst. The grant, which runs from July 2024 to June 2029, will fund research to investigate the biophysical and molecular mechanisms underlying a novel process of "meso-scale gap closure" in tissues undergoing epithelial-mesenchymal transition. The research aims to...
This Project Grant award, with Federal Grant ID R01GM157590, is funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The $305,426 award, effective September 15, 2024 through August 31, 2028, supports research to investigate tissue fluidity and flow patterns in cells undergoing partial epithelial-mesenchymal transition (PEMT). The primary awardee is Worcester Polytechnic Institute (WPI), which will...
This Project Grant award of $389,600.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research to investigate the physical mechanisms of 3D cell motility. The research aims to establish how distinct pools of actomyosin contractility are linked to the control of cytoplasmic hydraulic pressure to achieve 3D cell migration. Specific focus areas include understanding how the structure of the 3D extracellular...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) is funding research to investigate the role of mechanical cues in the extracellular matrix in regulating monocyte inflammation. The $406,250 award, which runs from January 1, 2025 to December 31, 2029, will support the development of human stem cell-based culture systems to study monocyte mechanobiology, the investigation of mechanical...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $471,625 in funding to the Marine Biological Laboratory (MBL) to advance research on the mechanisms that control epithelial tube development, orientation, and integrity. The project aims to expand understanding of fundamental processes that guide the organization and function of epithelial tissues, which form the building...
The National Institute of General Medical Sciences (NIGMS) awarded a $406,250 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, with a performance period from January 22, 2025 to December 31, 2029. The grant aims to develop new chemistries and engineering approaches to manipulate the dynamic nascent extracellular matrix within complex...

This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $440,454 to The Washington University to study epithelial cell mechanobiology in mechanically heterogeneous microenvironments. The project will investigate how epithelial cells sense and respond to extracellular matrix properties, force transmission, and nuclear mechanosensing in the context of processes like wound healing, tumor invasion, and embryogenesis. Key focus areas include understanding how epithelial cells sense and overcome extracellular wounds, how changes in extracellular matrix fiber alignment can enable force-effective cell migration, and how nuclear transport dysfunction links to epithelial disorder and migration. The project aims to uncover new perspectives on epithelial mechanobiology, such as mechanical memory and depth-sensing, that could inform therapies for developmental disorders, cancer, and wound healing. The award period runs from January 14, 2025 to November 30, 2029.

Generated 8/5/25, 4:24 AM